> 0 1 0 1 O
5 1 2 1 2 B-lower_bound
cm 3 5 3 5 I-lower_bound
or 6 8 6 8 O
aortic 9 15 9 15 B-chronic_disease
dissection 16 26 16 26 I-chronic_disease

All 0 3 27 30 O
patients 4 12 31 39 O
must 13 17 40 44 O
have 18 22 45 49 O
at 23 25 50 52 O
least 26 31 53 58 O
one 32 35 59 62 B-lower_bound
lesion 36 42 63 69 I-lower_bound
deemed 43 49 70 76 O
safe 50 54 77 81 O
to 55 57 82 84 O
biopsy 58 64 85 91 B-treatment
and 65 68 92 95 O
be 69 71 96 98 O
willing 72 79 99 106 O
to 80 82 107 109 O
undergo 83 90 110 117 O
a 91 92 118 119 O
mandatory 93 102 120 129 O
baseline 103 111 130 138 O
biopsy 112 118 139 145 O

Clinically 0 10 146 156 O
significant 11 22 157 168 O
peripheral 23 33 169 179 B-chronic_disease
vascular 34 42 180 188 I-chronic_disease
disease 43 50 189 196 I-chronic_disease
or 51 53 197 199 O
vascular 54 62 200 208 O
disease 63 70 209 216 O
, 70 71 216 217 O
including 72 81 218 227 O
rapidly 82 89 228 235 O
growing 90 97 236 243 O
aortic 98 104 244 250 B-chronic_disease
aneurysm 105 113 251 259 I-chronic_disease
or 114 116 260 262 O
abdominal 117 126 263 272 B-chronic_disease
aortic 127 133 273 279 I-chronic_disease
aneurysm 134 142 280 288 I-chronic_disease

Eligibility 0 11 289 300 O
for 12 15 301 304 O
patients 16 24 305 313 O
with 25 29 314 318 O
asymptomatic 30 42 319 331 O
and 43 46 332 335 O
a 47 48 336 337 O
previous 49 57 338 346 O
diagnosis 58 67 347 356 O
of 68 70 357 359 O
immune 71 77 360 366 O
or 78 80 367 369 O
inflammatory 81 93 370 382 O
colitis 94 101 383 390 B-chronic_disease

HBV 0 3 391 394 B-chronic_disease
- 3 4 394 395 O
or 4 6 395 397 O
HCV 7 10 398 401 B-chronic_disease
- 10 11 401 402 O
positive 11 19 402 410 O
patients 20 28 411 419 O
are 29 32 420 423 O
ineligible 33 43 424 434 O
because 44 51 435 442 O
of 52 54 443 445 O
potential 55 64 446 455 O
reactivation 65 77 456 468 O
of 78 80 469 471 O
hepatitis 81 90 472 481 B-chronic_disease
virus 91 96 482 487 I-chronic_disease
following 97 106 488 497 O
steroids 107 115 498 506 B-treatment

HIV 0 3 507 510 B-chronic_disease
- 3 4 510 511 O
positive 4 12 511 519 O
patients 13 21 520 528 O
on 22 24 529 531 O
antiretroviral 25 39 532 546 B-treatment
therapy 40 47 547 554 I-treatment
are 48 51 555 558 O
ineligible 52 62 559 569 O
because 63 70 570 577 O
of 71 73 578 580 O
potential 74 83 581 590 O
pharmacokinetic 84 99 591 606 B-treatment
interactions 100 112 607 619 I-treatment
with 113 117 620 624 O
study 118 123 625 630 O
drugs 124 129 631 636 O

Histologically 0 14 637 651 O
or 15 17 652 654 O
cytologically 18 31 655 668 O
confirmed 32 41 669 678 O
SCLC 42 46 679 683 B-cancer

Histologically 0 14 684 698 O
or 15 17 699 701 O
cytologically 18 31 702 715 O
confirmed 32 41 716 725 O
advanced 42 50 726 734 O
NSCLC 51 56 735 740 B-cancer

Histologically 0 14 741 755 O
or 15 17 756 758 O
cytologically 18 31 759 772 O
confirmed 32 41 773 782 O
advanced 42 50 783 791 O
colorectal 51 61 792 802 B-cancer
cancer 62 68 803 809 I-cancer

Hypertensive 0 12 810 822 B-chronic_disease
crisis 13 19 823 829 I-chronic_disease
or 20 22 830 832 O
hypertensive 23 35 833 845 B-chronic_disease
encephalopathy 36 50 846 860 I-chronic_disease

NYHA 0 4 861 865 B-clinical_variable
Class 5 10 866 871 B-lower_bound
II 11 13 872 874 I-lower_bound
or 14 16 875 877 O
greater 17 24 878 885 O
heart 25 30 886 891 B-chronic_disease
failure 31 38 892 899 I-chronic_disease

Patients 0 8 900 908 O
are 9 12 909 912 O
allowed 13 20 913 920 O
to 21 23 921 923 O
have 24 28 924 928 O
received 29 37 929 937 O
prior 38 43 938 943 B-treatment
PARP 44 48 944 948 I-treatment
inhibitors 49 59 949 959 I-treatment
( 60 61 960 961 I-treatment
PARPi 61 66 961 966 I-treatment
) 66 67 966 967 I-treatment
, 67 68 967 968 O
and/or 69 75 969 975 O
anti 76 80 976 980 B-treatment
- 80 81 980 981 I-treatment
angiogenesis 81 93 981 993 I-treatment
therapy 94 101 994 1001 I-treatment

Patients 0 8 1002 1010 O
are 9 12 1011 1014 O
allowed 13 20 1015 1022 O
to 21 23 1023 1025 O
have 24 28 1026 1030 O
received 29 37 1031 1039 O
prior 38 43 1040 1045 O
PARPi 44 49 1046 1051 B-treatment
, 49 50 1051 1052 O
and/or 51 57 1053 1059 O
anti 58 62 1060 1064 B-treatment
- 62 63 1064 1065 I-treatment
angiogenesis 63 75 1065 1077 I-treatment
therapy 76 83 1078 1085 I-treatment
including 84 93 1086 1095 O
but 94 97 1096 1099 O
not 98 101 1100 1103 O
limited 102 109 1104 1111 O
to 110 112 1112 1114 O
thalidomide 113 124 1115 1126 B-treatment
, 124 125 1126 1127 O
bevacizumab 126 137 1128 1139 B-treatment
, 137 138 1139 1140 O
sunitinib 139 148 1141 1150 B-treatment
, 148 149 1150 1151 O
sorafenib 150 159 1152 1161 B-treatment
, 159 160 1161 1162 O
or 161 163 1163 1165 O
other 164 169 1166 1171 O
anti 170 174 1172 1176 B-treatment
- 174 175 1176 1177 I-treatment
angiogenics 175 186 1177 1188 I-treatment

Patients 0 8 1189 1197 O
are 9 12 1198 1201 O
allowed 13 20 1202 1209 O
to 21 23 1210 1212 O
have 24 28 1213 1217 O
received 29 37 1218 1226 O
prior 38 43 1227 1232 B-treatment
anti 44 48 1233 1237 I-treatment
- 48 49 1237 1238 I-treatment
angiogenesis 49 61 1238 1250 I-treatment
therapy 62 69 1251 1258 I-treatment
with 70 74 1259 1263 O
the 75 78 1264 1267 O
exception 79 88 1268 1277 O
of 89 91 1278 1280 O
prior 92 97 1281 1286 B-treatment
cediranib 98 107 1287 1296 I-treatment

Patients 0 8 1297 1305 O
must 9 13 1306 1310 O
be 14 16 1311 1313 O
at 17 19 1314 1316 O
least 20 25 1317 1322 O
18 26 28 1323 1325 B-lower_bound
years 29 34 1326 1331 I-lower_bound
of 35 37 1332 1334 O
age 38 41 1335 1338 B-age

Patients 0 8 1339 1347 O
must 9 13 1348 1352 O
have 14 18 1353 1357 O
adequately 19 29 1358 1368 O
controlled 30 40 1369 1379 O
blood 41 46 1380 1385 O
pressure 47 55 1386 1394 O
on 56 58 1395 1397 O
a 59 60 1398 1399 O
maximum 61 68 1400 1407 O
of 69 71 1408 1410 O
three 72 77 1411 1416 B-upper_bound
antihypertensive 78 94 1417 1433 B-treatment
medications 95 106 1434 1445 I-treatment

Patients 0 8 1446 1454 O
must 9 13 1455 1459 O
have 14 18 1460 1464 O
at 19 21 1465 1467 O
least 22 27 1468 1473 O
one 28 31 1474 1477 B-lower_bound
focus 32 37 1478 1483 O
of 38 40 1484 1486 O
metastatic 41 51 1487 1497 B-cancer
disease 52 59 1498 1505 I-cancer
that 60 64 1506 1510 O
is 65 67 1511 1513 O
amenable 68 76 1514 1522 O
to 77 79 1523 1525 O
pre 80 83 1526 1529 O
- 83 84 1529 1530 O
and 84 87 1530 1533 O
on 88 90 1534 1536 O
- 90 91 1536 1537 O
treatment 91 100 1537 1546 B-treatment
biopsy 101 107 1547 1553 I-treatment

Patients 0 8 1554 1562 O
must 9 13 1563 1567 O
have 14 18 1568 1572 O
histologically 19 33 1573 1587 O
confirmed 34 43 1588 1597 O
persistent 44 54 1598 1608 O
or 55 57 1609 1611 O
recurrent 58 67 1612 1621 O
triple 68 74 1622 1628 B-cancer
- 74 75 1628 1629 I-cancer
negative 75 83 1629 1637 I-cancer
breast 84 90 1638 1644 I-cancer
cancer 91 97 1645 1651 I-cancer
( 98 99 1652 1653 I-cancer
TNBC 99 103 1653 1657 I-cancer
) 103 104 1657 1658 I-cancer

Patients 0 8 1659 1667 O
must 9 13 1668 1672 O
have 14 18 1673 1677 O
histologically 19 33 1678 1692 O
or 34 36 1693 1695 O
cytologically 37 50 1696 1709 O
confirmed 51 60 1710 1719 O
advanced 61 69 1720 1728 O
solid 70 75 1729 1734 B-cancer
tumor 76 81 1735 1740 I-cancer
that 82 86 1741 1745 O
is 87 89 1746 1748 O
refractory 90 100 1749 1759 O
to 101 103 1760 1762 O
standard 104 112 1763 1771 B-treatment
treatment 113 122 1772 1781 I-treatment
or 123 125 1782 1784 O
for 126 129 1785 1788 O
which 130 135 1789 1794 O
no 136 138 1795 1797 O
standard 139 147 1798 1806 O
treatment 148 157 1807 1816 O
exists 158 164 1817 1823 O
, 164 165 1823 1824 O
with 166 170 1825 1829 O
evaluable 171 180 1830 1839 O
disease 181 188 1840 1847 O

Patients 0 8 1848 1856 O
must 9 13 1857 1861 O
have 14 18 1862 1866 O
histologically 19 33 1867 1881 O
or 34 36 1882 1884 O
cytologically 37 50 1885 1898 O
confirmed 51 60 1899 1908 O
persistent 61 71 1909 1919 O
or 72 74 1920 1922 O
recurrent 75 84 1923 1932 O
ovarian 85 92 1933 1940 B-cancer
, 92 93 1940 1941 O
fallopian 94 103 1942 1951 B-cancer
tube 104 108 1952 1956 I-cancer
, 108 109 1956 1957 O
or 110 112 1958 1960 O
primary 113 120 1961 1968 B-cancer
peritoneal 121 131 1969 1979 I-cancer
cancer 132 138 1980 1986 I-cancer

Patients 0 8 1987 1995 O
must 9 13 1996 2000 O
have 14 18 2001 2005 O
metastatic 19 29 2006 2016 B-cancer
, 29 30 2016 2017 O
progressive 31 42 2018 2029 B-cancer
, 42 43 2029 2030 O
castrate 44 52 2031 2039 B-cancer
resistant 53 62 2040 2049 I-cancer
prostate 63 71 2050 2058 I-cancer
cancer 72 78 2059 2065 I-cancer
( 79 80 2066 2067 O
mCRPC 80 85 2067 2072 O
) 85 86 2072 2073 O

Patients 0 8 2074 2082 O
must 9 13 2083 2087 O
have 14 18 2088 2092 O
progressed 19 29 2093 2103 O
on 30 32 2104 2106 O
, 32 33 2106 2107 O
been 34 38 2108 2112 O
intolerant 39 49 2113 2123 O
of 50 52 2124 2126 O
or 53 55 2127 2129 O
refused 56 63 2130 2137 O
prior 64 69 2138 2143 B-treatment
oxaliplatin- 70 82 2144 2156 I-treatment
and 83 86 2157 2160 I-treatment
irinotecan 87 97 2161 2171 I-treatment
- 97 98 2171 2172 I-treatment
containing 98 108 2172 2182 I-treatment
chemotherapeutic 109 125 2183 2199 I-treatment
regimen 126 133 2200 2207 I-treatment
, 133 134 2207 2208 O
and 135 138 2209 2212 O
have 139 143 2213 2217 O
disease 144 151 2218 2225 O
that 152 156 2226 2230 O
is 157 159 2231 2233 O
not 160 163 2234 2237 O
amenable 164 172 2238 2246 O
to 173 175 2247 2249 O
potentially 176 187 2250 2261 O
curative 188 196 2262 2270 O
resection 197 206 2271 2280 O

Patients 0 8 2281 2289 O
must 9 13 2290 2294 O
have 14 18 2295 2299 O
received 19 27 2300 2308 O
prior 28 33 2309 2314 B-treatment
treatment 34 43 2315 2324 I-treatment
with 44 48 2325 2329 I-treatment
enzalutamide 49 61 2330 2342 I-treatment
and/or 62 68 2343 2349 I-treatment
abiraterone 69 80 2350 2361 I-treatment

Patients 0 8 2362 2370 O
must 9 13 2371 2375 O
have 14 18 2376 2380 O
undergone 19 28 2381 2390 O
bilateral 29 38 2391 2400 B-treatment
surgical 39 47 2401 2409 I-treatment
castration 48 58 2410 2420 I-treatment
or 59 61 2421 2423 O
must 62 66 2424 2428 O
agree 67 72 2429 2434 O
to 73 75 2435 2437 O
continue 76 84 2438 2446 O
on 85 87 2447 2449 O
GnRH 88 92 2450 2454 B-treatment
agonists 93 101 2455 2463 I-treatment
/ 101 102 2463 2464 O
antagonists 102 113 2464 2475 B-treatment
for 114 117 2476 2479 O
the 118 121 2480 2483 O
duration 122 130 2484 2492 O
of 131 133 2493 2495 O
the 134 137 2496 2499 O
study 138 143 2500 2505 O

Patients 0 8 2506 2514 O
who 9 12 2515 2518 O
have 13 17 2519 2523 O
a 18 19 2524 2525 O
known 20 25 2526 2531 O
KRAS 26 30 2532 2536 B-cancer
wild 31 35 2537 2541 I-cancer
type 36 40 2542 2546 I-cancer
tumor 41 46 2547 2552 I-cancer
must 47 51 2553 2557 O
have 52 56 2558 2562 O
progressed 57 67 2563 2573 O
, 67 68 2573 2574 O
been 69 73 2575 2579 O
intolerant 74 84 2580 2590 O
of 85 87 2591 2593 O
or 88 90 2594 2596 O
refused 91 98 2597 2604 O
cetuximab 99 108 2605 2614 B-treatment
or 109 111 2615 2617 O
panitumumab 112 123 2618 2629 B-treatment
- 123 124 2629 2630 I-treatment
based 124 129 2630 2635 I-treatment
chemotherapy 130 142 2636 2648 I-treatment

Patients 0 8 2649 2657 O
who 9 12 2658 2661 O
have 13 17 2662 2666 O
had 18 21 2667 2670 O
prior 22 27 2671 2676 B-treatment
PARPi 28 33 2677 2682 I-treatment
are 34 37 2683 2686 O
not 38 41 2687 2690 O
eligible 42 50 2691 2699 O

Patients 0 8 2700 2708 O
who 9 12 2709 2712 O
have 13 17 2713 2717 O
had 18 21 2718 2721 O
prior 22 27 2722 2727 B-treatment
immune 28 34 2728 2734 I-treatment
checkpoint 35 45 2735 2745 I-treatment
inhibitors 46 56 2746 2756 I-treatment
, 56 57 2756 2757 I-treatment
such 58 62 2758 2762 I-treatment
as 63 65 2763 2765 I-treatment
MEDI4736 66 74 2766 2774 I-treatment
or 75 77 2775 2777 I-treatment
other 78 83 2778 2783 I-treatment
PD1 84 87 2784 2787 I-treatment
or 88 90 2788 2790 I-treatment
PD 91 93 2791 2793 I-treatment
- 93 94 2793 2794 I-treatment
L1 94 96 2794 2796 I-treatment
inhibitors 97 107 2797 2807 I-treatment
or 108 110 2808 2810 I-treatment
an 111 113 2811 2813 I-treatment
anti 114 118 2814 2818 I-treatment
- 118 119 2818 2819 I-treatment
CTLA4 119 124 2819 2824 I-treatment
therapy 125 132 2825 2832 I-treatment
are 133 136 2833 2836 O
not 137 140 2837 2840 O
eligible 141 149 2841 2849 O

Patients 0 8 2850 2858 O
who 9 12 2859 2862 O
have 13 17 2863 2867 O
had 18 21 2868 2871 O
prior 22 27 2872 2877 B-treatment
treatment 28 37 2878 2887 I-treatment
with 38 42 2888 2892 I-treatment
PARPi 43 48 2893 2898 I-treatment
are 49 52 2899 2902 O
not 53 56 2903 2906 O
eligible 57 65 2907 2915 O

Patients 0 8 2916 2924 O
who 9 12 2925 2928 O
have 13 17 2929 2933 O
had 18 21 2934 2937 O
progression 22 33 2938 2949 O
of 34 36 2950 2952 O
prostate 37 45 2953 2961 B-cancer
cancer 46 52 2962 2968 I-cancer
on 53 55 2969 2971 O
prior 56 61 2972 2977 B-treatment
docetaxel 62 71 2978 2987 I-treatment
treatment 72 81 2988 2997 I-treatment
for 82 85 2998 3001 O
castrate 86 94 3002 3010 B-cancer
sensitive 95 104 3011 3020 I-cancer
disease 105 112 3021 3028 I-cancer
are 113 116 3029 3032 O
ineligible 117 127 3033 3043 O

Patients 0 8 3044 3052 O
who 9 12 3053 3056 O
have 13 17 3057 3061 O
had 18 21 3062 3065 O
treatment 22 31 3066 3075 B-treatment
with 32 36 3076 3080 I-treatment
docetaxel 37 46 3081 3090 I-treatment
for 47 50 3091 3094 O
the 51 54 3095 3098 O
treatment 55 64 3099 3108 O
of 65 67 3109 3111 O
metastatic 68 78 3112 3122 B-cancer
castrate 79 87 3123 3131 I-cancer
- 87 88 3131 3132 I-cancer
sensitive 88 97 3132 3141 I-cancer
prostate 98 106 3142 3150 I-cancer
cancer 107 113 3151 3157 I-cancer

Patients 0 8 3158 3166 O
who 9 12 3167 3170 O
have 13 17 3171 3175 O
received 18 26 3176 3184 O
anti 27 31 3185 3189 B-treatment
- 31 32 3189 3190 I-treatment
angiogenesis 32 44 3190 3202 I-treatment
therapy 45 52 3203 3210 I-treatment
are 53 56 3211 3214 O
eligible 57 65 3215 3223 O

Patients 0 8 3224 3232 O
who 9 12 3233 3236 O
have 13 17 3237 3241 O
received 18 26 3242 3250 O
more 27 31 3251 3255 O
than 32 36 3256 3260 O
three 37 42 3261 3266 B-lower_bound
lines 43 48 3267 3272 O
of 49 51 3273 3275 O
prior 52 57 3276 3281 B-treatment
therapy 58 65 3282 3289 I-treatment
in 66 68 3290 3292 O
the 69 72 3293 3296 O
metastatic 73 83 3297 3307 B-cancer
or 84 86 3308 3310 O
recurrent 87 96 3311 3320 O
settings 97 105 3321 3329 O
are 106 109 3330 3333 O
not 110 113 3334 3337 O
eligible 114 122 3338 3346 O

Patients 0 8 3347 3355 O
who 9 12 3356 3359 O
have 13 17 3360 3364 O
received 18 26 3365 3373 O
prior 27 32 3374 3379 B-treatment
PARPi 33 38 3380 3385 I-treatment
or 39 41 3386 3388 O
immune 42 48 3389 3395 B-treatment
checkpoint 49 59 3396 3406 I-treatment
inhibitors 60 70 3407 3417 I-treatment
are 71 74 3418 3421 O
ineligible 75 85 3422 3432 O

Patients 0 8 3433 3441 O
who 9 12 3442 3445 O
have 13 17 3446 3450 O
received 18 26 3451 3459 O
radionuclide 27 39 3460 3472 B-treatment
treatment 40 49 3473 3482 I-treatment

Patients 0 8 3483 3491 O
who 9 12 3492 3495 O
were 13 17 3496 3500 O
previously 18 28 3501 3511 B-treatment
treated 29 36 3512 3519 I-treatment
with 37 41 3520 3524 I-treatment
cediranib 42 51 3525 3534 I-treatment
are 52 55 3535 3538 O
ineligible 56 66 3539 3549 O

Patients 0 8 3550 3558 O
with 9 13 3559 3563 O
a 14 15 3564 3565 O
history 16 23 3566 3573 O
of 24 26 3574 3576 O
allergic 27 35 3577 3585 O
reactions 36 45 3586 3595 O
attributed 46 56 3596 3606 O
to 57 59 3607 3609 O
compounds 60 69 3610 3619 O
of 70 72 3620 3622 O
similar 73 80 3623 3630 O
chemical 81 89 3631 3639 O
or 90 92 3640 3642 O
biologic 93 101 3643 3651 O
composition 102 113 3652 3663 O
to 114 116 3664 3666 O
MEDI4736 117 125 3667 3675 B-allergy_name
, 125 126 3675 3676 O
olaparib 127 135 3677 3685 B-allergy_name
, 135 136 3685 3686 O
cediranib 137 146 3687 3696 B-allergy_name
, 146 147 3696 3697 O
or 148 150 3698 3700 O
to 151 153 3701 3703 O
other 154 159 3704 3709 O
humanized 160 169 3710 3719 B-allergy_name
monoclonal 170 180 3720 3730 I-allergy_name
antibodies 181 191 3731 3741 I-allergy_name
, 191 192 3741 3742 O
or 193 195 3743 3745 O
a 196 197 3746 3747 O
history 198 205 3748 3755 O
of 206 208 3756 3758 O
anaphylaxis 209 220 3759 3770 O
, 220 221 3770 3771 O
angioedema 222 232 3772 3782 B-chronic_disease
, 232 233 3782 3783 O
laryngeal 234 243 3784 3793 B-chronic_disease
edema 244 249 3794 3799 I-chronic_disease
, 249 250 3799 3800 O
serum 251 256 3801 3806 B-chronic_disease
sickness 257 265 3807 3815 I-chronic_disease
, 265 266 3815 3816 O
or 267 269 3817 3819 O
uncontrolled 270 282 3820 3832 O
asthma 283 289 3833 3839 B-chronic_disease
, 289 290 3839 3840 O
are 291 294 3841 3844 O
not 295 298 3845 3848 O
eligible 299 307 3849 3857 O

Patients 0 8 3858 3866 O
with 9 13 3867 3871 O
a 14 15 3872 3873 O
history 16 23 3874 3881 O
of 24 26 3882 3884 O
auto 27 31 3885 3889 B-chronic_disease
- 31 32 3889 3890 I-chronic_disease
immune 32 38 3890 3896 I-chronic_disease
disease 39 46 3897 3904 I-chronic_disease
requiring 47 56 3905 3914 O
steroid 57 64 3915 3922 B-treatment
maintenance 65 76 3923 3934 O
, 76 77 3934 3935 O
or 78 80 3936 3938 O
history 81 88 3939 3946 O
of 89 91 3947 3949 O
primary 92 99 3950 3957 B-chronic_disease
immunodeficiency 100 116 3958 3974 I-chronic_disease
are 117 120 3975 3978 O
not 121 124 3979 3982 O
eligible 125 133 3983 3991 O

Patients 0 8 3992 4000 O
with 9 13 4001 4005 O
a 14 15 4006 4007 O
history 16 23 4008 4015 O
of 24 26 4016 4018 O
cerebrovascular 27 42 4019 4034 B-chronic_disease
accident 43 51 4035 4043 I-chronic_disease
or 52 54 4044 4046 O
transient 55 64 4047 4056 B-chronic_disease
ischemic 65 73 4057 4065 I-chronic_disease
attack 74 80 4066 4072 I-chronic_disease

Patients 0 8 4073 4081 O
with 9 13 4082 4086 O
a 14 15 4087 4088 O
history 16 23 4089 4096 O
of 24 26 4097 4099 O
previous 27 35 4100 4108 O
clinical 36 44 4109 4117 O
diagnosis 45 54 4118 4127 O
of 55 57 4128 4130 O
tuberculosis 58 70 4131 4143 B-chronic_disease
are 71 74 4144 4147 O
not 75 78 4148 4151 O
eligible 79 87 4152 4160 O

Patients 0 8 4161 4169 O
with 9 13 4170 4174 O
any 14 17 4175 4178 O
cardiac 18 25 4179 4186 O
history 26 33 4187 4194 O
of 34 36 4195 4197 O
the 37 40 4198 4201 O
following 41 50 4202 4211 O
conditions 51 61 4212 4222 O
within 62 68 4223 4229 O
1 69 70 4230 4231 B-upper_bound
year 71 75 4232 4236 I-upper_bound
prior 76 81 4237 4242 I-upper_bound
to 82 84 4243 4245 O
study 85 90 4246 4251 O
enrollment 91 101 4252 4262 O

Patients 0 8 4263 4271 O
with 9 13 4272 4276 O
any 14 17 4277 4280 O
other 18 23 4281 4286 O
concomitant 24 35 4287 4298 O
or 36 38 4299 4301 O
prior 39 44 4302 4307 O
invasive 45 53 4308 4316 O
malignancies 54 66 4317 4329 B-cancer
are 67 70 4330 4333 O
ineligible 71 81 4334 4344 O

Patients 0 8 4345 4353 O
with 9 13 4354 4358 O
both 14 18 4359 4363 O
platinum 19 27 4364 4372 B-chronic_disease
- 27 28 4372 4373 I-chronic_disease
sensitive 28 37 4373 4382 I-chronic_disease
and 38 41 4383 4386 O
platinum 42 50 4387 4395 B-chronic_disease
- 50 51 4395 4396 I-chronic_disease
refractory 51 61 4396 4406 I-chronic_disease
disease 62 69 4407 4414 I-chronic_disease
will 70 74 4415 4419 O
be 75 77 4420 4422 O
eligible 78 86 4423 4431 O

Patients 0 8 4432 4440 O
with 9 13 4441 4445 O
prior 14 19 4446 4451 O
history 20 27 4452 4459 O
of 28 30 4460 4462 O
pneumonitis 31 42 4463 4474 B-chronic_disease
and/or 43 49 4475 4481 O
interstitial 50 62 4482 4494 B-chronic_disease
lung 63 67 4495 4499 I-chronic_disease
disease 68 75 4500 4507 I-chronic_disease
will 76 80 4508 4512 O
be 81 83 4513 4515 O
excluded 84 92 4516 4524 O

Pregnant 0 8 4525 4533 B-pregnancy
and 9 12 4534 4537 O
breastfeeding 13 26 4538 4551 O
women 27 32 4552 4557 B-gender
are 33 36 4558 4561 O
excluded 37 45 4562 4570 O
from 46 50 4571 4575 O
this 51 55 4576 4580 O
study 56 61 4581 4586 O

Prior 0 5 4587 4592 O
cardiac 6 13 4593 4600 B-chronic_disease
arrhythmia 14 24 4601 4611 I-chronic_disease
including 25 34 4612 4621 O
atrial 35 41 4622 4628 B-chronic_disease
fibrillation 42 54 4629 4641 I-chronic_disease
and 55 58 4642 4645 O
atrial 59 65 4646 4652 B-chronic_disease
flutter 66 73 4653 4660 I-chronic_disease
, 73 74 4660 4661 O
or 75 77 4662 4664 O
requiring 78 87 4665 4674 O
concurrent 88 98 4675 4685 O
use 99 102 4686 4689 O
of 103 105 4690 4692 O
drugs 106 111 4693 4698 O
or 112 114 4699 4701 O
biologics 115 124 4702 4711 B-treatment
with 125 129 4712 4716 O
pro 130 133 4717 4720 B-treatment
- 133 134 4720 4721 I-treatment
arrhythmic 134 144 4721 4731 I-treatment
potential 145 154 4732 4741 O

Prior 0 5 4742 4747 O
events 6 12 4748 4754 O
including 13 22 4755 4764 O
myocardial 23 33 4765 4775 B-chronic_disease
infarction 34 44 4776 4786 I-chronic_disease
, 44 45 4786 4787 O
pericardial 46 57 4788 4799 B-chronic_disease
effusion 58 66 4800 4808 I-chronic_disease
, 66 67 4808 4809 O
and 68 71 4810 4813 O
myocarditis 72 83 4814 4825 B-chronic_disease

QTc 0 3 4826 4829 B-clinical_variable
prolongation 4 16 4830 4842 I-clinical_variable
> 17 18 4843 4844 O
470 18 21 4844 4847 B-lower_bound
msec 22 26 4848 4852 I-lower_bound

Unstable 0 8 4853 4861 B-chronic_disease
angina 9 15 4862 4868 I-chronic_disease

have 0 4 4869 4873 O
received 5 13 4874 4882 O
at 14 16 4883 4885 O
least 17 22 4886 4891 O
two 23 26 4892 4895 B-lower_bound
prior 27 32 4896 4901 O
platinum 33 41 4902 4910 B-treatment
- 41 42 4910 4911 I-treatment
containing 42 52 4911 4921 I-treatment
regimens 53 61 4922 4930 I-treatment
or 62 64 4931 4933 O
who 65 68 4934 4937 O
are 69 72 4938 4941 O
platinum 73 81 4942 4950 O
resistant 82 91 4951 4960 O
or 92 94 4961 4963 O
refractory 95 105 4964 4974 O
during 106 112 4975 4981 O
or 113 115 4982 4984 O
after 116 121 4985 4990 O
a 122 123 4991 4992 O
first 124 129 4993 4998 O
platinum 130 138 4999 5007 B-treatment
containing 139 149 5008 5018 I-treatment
regimen 150 157 5019 5026 I-treatment

other 0 5 5027 5032 O
significant 6 17 5033 5044 O
ECG 18 21 5045 5048 B-treatment
abnormality 22 33 5049 5060 O
noted 34 39 5061 5066 O
within 40 46 5067 5073 O
14 47 49 5074 5076 B-upper_bound
days 50 54 5077 5081 I-upper_bound
of 55 57 5082 5084 O
treatment 58 67 5085 5094 B-treatment

patients 0 8 5095 5103 O
must 9 13 5104 5108 O
not 14 17 5109 5112 O
have 18 22 5113 5117 O
received 23 31 5118 5126 O
other 32 37 5127 5132 O
anti 38 42 5133 5137 B-treatment
- 42 43 5137 5138 I-treatment
angiogenesis 43 55 5138 5150 I-treatment
therap(ies 56 66 5151 5161 I-treatment
) 66 67 5161 5162 I-treatment
within 68 74 5163 5169 O
6 75 76 5170 5171 B-upper_bound
months 77 83 5172 5178 I-upper_bound
prior 84 89 5179 5184 I-upper_bound
to 90 92 5185 5187 O
study 93 98 5188 5193 O
enrollment 99 109 5194 5204 O

patients 0 8 5205 5213 O
who 9 12 5214 5217 O
were 13 17 5218 5222 O
treated 18 25 5223 5230 O
with 26 30 5231 5235 O
both 31 35 5236 5240 O
olaparib 36 44 5241 5249 B-treatment
and 45 48 5250 5253 O
cediranib 49 58 5254 5263 B-treatment
, 58 59 5263 5264 O
either 60 66 5265 5271 O
in 67 69 5272 5274 O
combination 70 81 5275 5286 O
or 82 84 5287 5289 O
sequentially 85 97 5290 5302 O
are 98 101 5303 5306 O
not 102 105 5307 5310 O
eligible 106 114 5311 5319 O

patients 0 8 5320 5328 O
who 9 12 5329 5332 O
were 13 17 5333 5337 O
treated 18 25 5338 5345 O
with 26 30 5346 5350 O
cediranib 31 40 5351 5360 B-treatment
, 40 41 5360 5361 O
either 42 48 5362 5368 O
in 49 51 5369 5371 O
combination 52 63 5372 5383 O
or 64 66 5384 5386 O
monotherapy 67 78 5387 5398 B-treatment
are 79 82 5399 5402 O
not 83 86 5403 5406 O
eligible 87 95 5407 5415 O

patients 0 8 5416 5424 O
with 9 13 5425 5429 O
chronic 14 21 5430 5437 B-clinical_variable
diarrhea 22 30 5438 5446 I-clinical_variable
> 31 32 5447 5448 O
1 33 34 5449 5450 B-lower_bound
month 35 40 5451 5456 I-lower_bound
without 41 48 5457 5464 O
immune 49 55 5465 5471 B-chronic_disease
or 56 58 5472 5474 O
inflammatory 59 71 5475 5487 B-chronic_disease
colitis 72 79 5488 5495 I-chronic_disease
is 80 82 5496 5498 O
a 83 84 5499 5500 O
PI 85 87 5501 5503 O
decision 88 96 5504 5512 O
on 97 99 5513 5515 O
an 100 102 5516 5518 O
individual 103 113 5519 5529 O
patient 114 121 5530 5537 O
basis 122 127 5538 5543 O

with 0 4 5544 5548 O
at 5 7 5549 5551 O
least 8 13 5552 5557 O
one 14 17 5558 5561 B-lower_bound
prior 18 23 5562 5567 B-treatment
line 24 28 5568 5572 I-treatment
of 29 31 5573 5575 I-treatment
platinum 32 40 5576 5584 I-treatment
- 40 41 5584 5585 I-treatment
based 41 46 5585 5590 I-treatment
chemotherapy 47 59 5591 5603 I-treatment

with 0 4 5604 5608 O
at 5 7 5609 5611 O
least 8 13 5612 5617 O
one 14 17 5618 5621 B-lower_bound
prior 18 23 5622 5627 B-treatment
line 24 28 5628 5632 I-treatment
of 29 31 5633 5635 I-treatment
platinum 32 40 5636 5644 I-treatment
- 40 41 5644 5645 I-treatment
based 41 46 5645 5650 I-treatment
chemotherapy 47 59 5651 5663 I-treatment
are 60 63 5664 5667 O
eligible 64 72 5668 5676 O

within 0 6 5677 5683 O
6 7 8 5684 5685 B-upper_bound
months 9 15 5686 5692 I-upper_bound
before 16 22 5693 5699 O
the 23 26 5700 5703 O
first 27 32 5704 5709 O
dose 33 37 5710 5714 O
of 38 40 5715 5717 O
study 41 46 5718 5723 B-treatment
treatment 47 56 5724 5733 I-treatment
are 57 60 5734 5737 O
not 61 64 5738 5741 O
eligible 65 73 5742 5750 O

within 0 6 5751 5757 O
6 7 8 5758 5759 B-upper_bound
weeks 9 14 5760 5765 I-upper_bound
prior 15 20 5766 5771 I-upper_bound
to 21 23 5772 5774 O
the 24 27 5775 5778 O
first 28 33 5779 5784 B-treatment
dose 34 38 5785 5789 I-treatment
of 39 41 5790 5792 I-treatment
the 42 45 5793 5796 I-treatment
study 46 51 5797 5802 I-treatment
treatment 52 61 5803 5812 I-treatment
are 62 65 5813 5816 O
not 66 69 5817 5820 O
eligible 70 78 5821 5829 O

